/
CPHI
$0.63+$0.01 (+1.98%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$24.9M
41M shares
52-week range
$0.38 – $2.03
15% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Price (6 mo)
Loading chart…
Change$-360.97
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.3M | $10.9M | $10.9M | $9.6M | $8.1M | $7.0M | $4.5M | $4.1M |
| Cost of revenue | $10.4M | $9.4M | $8.9M | $9.3M | $8.6M | $7.3M | $6.5M | $4.3M |
| Gross profit | $2.0M | $1.5M | $2.0M | $349.3K | −$493.9K | −$281.1K | −$2.0M | −$131.9K |
| Gross margin | 16.0% | 13.6% | 18.0% | 3.6% | -6.1% | -4.0% | -43.8% | -3.2% |
| R&D | $172.4K | $229.6K | $378.0K | $319.0K | $185.9K | $240.1K | $283.9K | $280.9K |
| Operating income | −$4.0M | −$3.4M | −$2.6M | −$2.9M | −$3.5M | −$2.8M | −$4.6M | −$3.1M |
| EBITDA | −$7.2M | −$17.5M | $106.9K | $230.3K | −$837.7K | $8.4K | −$2.0M | −$1.5M |
| Net income | −$10.8M | −$20.7M | −$2.9M | −$3.4M | −$4.0M | −$3.1M | −$4.7M | −$3.2M |
| Net margin | -87.2% | -189.5% | -26.4% | -35.3% | -49.0% | -43.9% | -104.6% | -76.9% |
| EPS (diluted) | -2.47 | -4.82 | -0.72 | -0.85 | -1.94 | -0.29 | -0.27 | -0.74 |
Annual figures · source: Financial Modeling Prep
Peer comparison
China Pharma Holdings, Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
www.chinapharmaholdings.com- Employees
- 221
- IPO / List date
- Apr 14, 2002
- HQ
- HAINAN PROVINCE, F4
Held by traders on TradeandTell
No one on the platform currently holds CPHI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 11,418 | $7.0K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-04-15 | 1-for-10reverse |
| 2024-03-06 | 1-for-5reverse |
| 2023-03-06 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded CPHI yet.
